Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
BEMER is a private medical device company best known for its pulsed electromagnetic field-based BEMER Therapy systems, which are marketed as powered muscle stimulators intended to temporarily improve local blood circulation in healthy muscles. The company says it was founded in 1998 and operates internationally, with BEMER USA, LLC serving as a subsidiary of BEMER Int. AG. Its products are positioned across human wellness, sports/performance, beauty, and equine use cases, and the company emphasizes proprietary signal technology, international patents, and regulated device quality systems. In the United States, BEMER markets FDA Class II cleared consumer medical devices rather than therapeutics for diagnosis or treatment of disease. For a biotech analyst, BEMER is best classified as a commercial-stage medtech and wellness company centered on PEMF-based circulation and muscle stimulation devices rather than a drug-development biotech.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on BEMER.